Small organic molecules-based NIR agents in cancer diagnostics: New frontiers in imaging and therapy
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Photoacoustic and Ultrasonic Imaging
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Cancer statistics, 2024, CA10.3322/caac.21820 ↗
2. Recent applications of near-infrared spectroscopy in cancer diagnosis and therapy10.1007/s00216-007-1651-y ↗
3. Near-infrared (NIR) fluorescence-emitting small organic molecules for cancer imaging and therapy10.1039/D2CS00722C ↗
4. Interventional NIR fluorescence imaging of cancer: review on next generation of dye-loaded protein-based nanoparticles for real-time feedback during cancer surgery10.2147/IJN.S295234 ↗
5. Phenylthiol-BODIPY-based supramolecular metallacycles for synergistic tumor chemo-photodynamic therapy10.1073/pnas.2203994119 ↗
6. Supramolecular coordination complexes for synergistic cancer therapy10.1021/acs.accounts.4c00031 ↗
7. Near-infrared boron–dipyrrin (BODIPY) nanomaterials: molecular design and anti-tumor therapeutics10.1016/j.ccr.2024.215718 ↗
8. Chalcogen modification: one-step strategy for tuning the photophysical properties and NIR phototherapy of iodinated BODIPY10.1039/D4QM00508B ↗
9. Rational design of amphiphilic BODIPY-based photosensitizers for multimodal imaging-guided phototherapy10.1039/D3QM00239J ↗
10. Near-infrared-II (NIR-II) bioimaging via off-peak NIR-I fluorescence emission10.7150/thno.27995 ↗
11. Recent advances in near-infrared I/II persistent luminescent nanoparticles for biosensing and bioimaging in cancer analysis10.1007/s00216-024-05267-z ↗
12. Design and application of organic contrast agents for molecular imaging in the second near infrared (NIR-II) window10.1016/j.pacs.2022.100426 ↗
13. Organic semiconducting agents for deep-tissue molecular imaging: second near-infrared fluorescence, self-luminescence, and photoacoustics10.1002/adma.201801778 ↗
14. Near-infrared fluorescent nanomaterials for bioimaging and sensing10.1002/adom.201600446 ↗
15. NIR luminescent nanomaterials for biomedical imaging10.1039/c3tb21447h ↗
16. Nanocrystals for deep-tissue in vivo luminescence imaging in the near-infrared region10.1021/acs.chemrev.3c00506 ↗
17. NIR-II light in clinical oncology: opportunities and challenges10.1038/s41571-024-00892-0 ↗
18. Near-infrared-II molecular dyes for cancer imaging and surgery10.1002/adma.201900321 ↗
19. Non-invasive molecular imaging for precision diagnosis of metastatic lymph nodes: opportunities from preclinical to clinical applications10.1007/s00259-022-06056-5 ↗
20. Recent progresses in NIR-I/II fluorescence imaging for surgical navigation
21. Diagnostic and monitoring applications using near infrared (NIR) spectroscopy in cancer and other diseases10.1016/j.pdpdt.2023.103633 ↗
22. Molecular engineering of bright NIR-I/NIR-II nanofluorophores for high-resolution bioimaging and tumor detection in vivo10.1021/acs.nanolett.3c04976 ↗
23. A molecular design strategy toward enzyme-activated probes with near-infrared I and II fluorescence for targeted cancer imaging10.1039/C9SC02093D ↗
24. The future of early cancer detection10.1038/s41591-022-01746-x ↗
25. Esophageal cancer screening, early detection and treatment: current insights and future directions10.4251/wjgo.v16.i4.1180 ↗
26. Fluorescence imaging for cancer screening and surveillance10.1007/s11307-017-1050-5 ↗
27. Molecular imaging biomarkers for early cancer detection: a systematic review of emerging technologies and clinical applications10.3390/diagnostics14212459 ↗
28. Current trends and advances in nanoplatforms-based imaging for cancer diagnosis
29. Biomarkers in molecular medicine: cancer detection and diagnosis10.2144/05384SU04 ↗
30. Joshi · 2010 · vol. 2 · 1251
31. Small molecular NIR-II fluorophores for cancer phototheranostics
32. Principles and applications of miniaturized near-infrared (NIR) spectrometers10.1002/chem.202002838 ↗
33. Near-infrared spectroscopy and hyperspectral imaging: non-destructive analysis of biological materials10.1039/C4CS00062E ↗
34. Advanced optical imaging technology in the near infrared window for cell tracking in vivo10.1016/j.ccr.2024.216178 ↗
35. A review of NIR dyes in cancer targeting and imaging10.1016/j.biomaterials.2011.06.024 ↗
36. A novel multimodal NIR-II nanoprobe for the detection of metastatic lymph nodes and targeting chemo-photothermal therapy in oral squamous cell carcinoma10.7150/thno.30268 ↗
37. Revisiting the classification of NIR-absorbing/emitting nanomaterials for in vivo bioapplications10.1038/am.2016.106 ↗
38. Activatable fluorescence probes for “turn-on” and ratiometric biosensing and bioimaging: from NIR-I to NIR-II10.1021/acs.bioconjchem.9b00734 ↗
39. Recent advances in second near-infrared region (NIR-II) fluorophores and biomedical applications10.3389/fchem.2021.750404 ↗
40. Biomedical applications of NIR-II organic small molecule fluorescent probes in different organs10.1016/j.ccr.2024.216122 ↗
41. Multifunctional near-infrared (NIR) phosphors with NIR i and NIR II luminescence for biological detection10.1021/acsaelm.1c01078 ↗
42. A small-molecule dye for NIR-II imaging
43. Recent advances of versatile fluorophores for multifunctional biomedical imaging in the NIR-II region10.1039/D4TB01957A ↗
44. A bright organic NIR-II nanofluorophore for three-dimensional imaging into biological tissues
45. Expanding NIR-II lanthanide toolboxes for improved biomedical imaging and detection10.1021/accountsmr.2c00117 ↗
46. NIR-II bioimaging of small organic molecule10.1016/j.biomaterials.2021.120717 ↗
47. NIR-I-to-NIR-II fluorescent nanomaterials for biomedical imaging and cancer therapy10.1039/C7TB02573D ↗
48. Recent advances of optical imaging in the second near-infrared window
49. Recent advances in near-infrared-II fluorescence imaging for deep-tissue molecular analysis and cancer diagnosis10.1002/smll.202202035 ↗
50. NIR fluorescence imaging and treatment for cancer immunotherapy10.1136/jitc-2022-004936 ↗
51. Organic single molecule based nano-platform for NIR-II imaging and chemo-photothermal synergistic treatment of tumor10.1016/j.biomaterials.2022.121670 ↗
52. Design of NIR-II high performance organic small molecule fluorescent probes and summary of their biomedical applications10.1016/j.ccr.2022.214609 ↗
53. Recent development of near-infrared photoacoustic probes based on small-molecule organic dye10.1039/D0CB00225A ↗
54. Near-infrared fluorescence heptamethine carbocyanine dyes mediate imaging and targeted drug delivery for human brain tumor10.1016/j.biomaterials.2015.07.028 ↗
55. A review of NIR dyes in cancer targeting and imaging10.1016/j.biomaterials.2011.06.024 ↗
56. Oral cancer: clinical features10.1016/j.oraloncology.2010.03.009 ↗
57. The pathology of oral cancer
58. The pathology of oral cancer10.1080/00310290310001602558 ↗
59. Oral cancer treatment10.1007/s11864-003-0029-4 ↗
60. New insights into oral cancer—risk factors and prevention: a review of literature10.4103/ijpvm.IJPVM_403_18 ↗
61. Use of indocyanine green near-infrared imaging for sentinel lymph node biopsy in early oral squamous cell carcinoma: a pilot study10.1007/s11307-024-01903-3 ↗
62. A real-time near-infrared fluorescence imaging method for the detection of oral cancers in mice using an indocyanine green–labeled podoplanin antibody10.1177/1533033818767936 ↗
63. Real-time surveillance of surgical margins via ICG-based near-infrared fluorescence imaging in patients with OSCC10.1186/s12957-020-01874-z ↗
64. Clinical application of indocyanine green fluorescence navigation technology to determine the safe margin of advanced oral squamous cell carcinoma10.21037/gs-22-33 ↗
65. ανβ3 integrin-targeted ICG-derived probes for imaging-guided surgery and photothermal therapy of oral cancer10.1039/D3AN01761C ↗
66. In vivo oral sentinel lymph node mapping by near-infrared fluorescent methylene blue in rats10.3390/diagnostics12112574 ↗
67. Enhancing NIR-II imaging and photothermal therapy for improved oral cancer theranostics by combining TICT and aggregation-induced emission
68. A novel near-infrared EGFR targeting probe for metastatic lymph node imaging in preclinical mouse models10.1186/s12951-023-02101-z ↗
69. A c-MET-targeted topical fluorescent probe cMBP-ICG improves oral squamous cell carcinoma detection in humans10.1245/s10434-022-12532-x ↗
70. Breast cancer statistics10.3322/caac.21754 ↗
71. Breast cancer10.1038/s41572-019-0111-2 ↗
72. Modular design of high-brightness pH-activatable near-infrared BODIPY probes for noninvasive fluorescence detection of deep-seated early breast cancer bone metastasis: remarkable axial substituent effect on performance10.1021/acscentsci.1c01066 ↗
73. NIR fluorescent imaging and photodynamic therapy with a novel theranostic phospholipid probe for triple-negative breast cancer cells10.1021/acs.bioconjchem.1c00295 ↗
74. Structure-based design of a selective class I histone deacetylase (HDAC) near-infrared (NIR) probe for epigenetic regulation detection in triple-negative breast cancer (TNBC)10.1021/acs.jmedchem.0c02161 ↗
75. Evolving an ultra-sensitive near-infrared β-galactosidase fluorescent probe for breast cancer imaging and surgical resection navigation10.1021/acssensors.2c01752 ↗
76. Near-infrared dye IRDye800CW-NHS coupled to Trastuzumab for near-infrared II fluorescence imaging in tumor xenograft models of HER-2-positive breast cancer10.1039/D3TB01486J ↗
77. Lung cancer statistics, 202310.1002/cncr.35128 ↗
78. Synthesis of a single-stranded DNA aptamer modified near-infrared, water-soluble fluorophore for lung cancer cell imaging
79. In vivo near-infrared fluorescence/ratiometric photoacoustic duplex imaging of lung cancer-specific hNQO110.1021/acs.analchem.2c02153 ↗
80. Diagnosing orthotopic lung tumor using a NTR-activatable near-infrared fluorescent probe by tracheal inhalation10.1021/acs.analchem.3c02760 ↗
81. Glutathione-activated near-infrared II fluorescent probe for lung metastatic diagnosis and intraoperative imaging of tumor
82. Liver cancer in 2021: global burden of disease study
83. Development of a novel melatonin-modified near-infrared fluorescent probe for in vivo hepatocellular carcinoma imaging10.1039/D0AY01135E ↗
84. Rational design of a highly selective near-infrared two-photon fluorogenic probe for imaging orthotopic hepatocellular carcinoma chemotherapy10.1002/anie.202101190 ↗
85. A near-infrared naphthalimide fluorescent probe for targeting the lysosomes of liver cancer cells and specifically selecting HSA10.1016/j.snb.2021.131015 ↗
86. Liver injury long-term monitoring and fluorescent image-guided tumor surgery using self-assembly amphiphilic donor-acceptor NIR-II dyes10.1016/j.bios.2022.114371 ↗
87. NIR-II-excited off-on-off fluorescent nanoprobes for sensitive molecular imaging in vivo
88. Dual-locked fluorescent probes activated by aminopeptidase N and the tumor redox environment for high-precision imaging of tumor boundaries10.1002/anie.202406332 ↗
89. Brain and other central nervous system tumor statistics, 202110.3322/caac.21693 ↗
90. NIR-II fluorescence visualization of ultrasound-induced blood–brain barrier opening for enhanced photothermal therapy against glioblastoma using indocyanine green microbubbles10.1016/j.scib.2022.10.025 ↗
91. Photostable small-molecule NIR-II fluorescent scaffolds that cross the blood-brain barrier for noninvasive brain imaging10.1021/jacs.2c11223 ↗
92. Llaguno-Munive
93. NIR-II perylene monoimide-based photothermal agent with strengthened donor–acceptor conjugation for deep orthotopic glioblastoma phototheranostics10.1002/smll.202300203 ↗
94. Preclinical assessment of IRDye800CW-labeled gastrin-releasing peptide receptor-targeting peptide for near infrared-II imaging of brain malignancies10.1002/btm2.10532 ↗
95. Incidence and mortality of ovarian cancer at the global, regional, and national levels, 1990–201710.1016/j.ygyno.2020.07.008 ↗
96. Specific near-infrared probe for ultrafast imaging of lysosomal β-galactosidase in ovarian cancer cells10.1021/acs.analchem.9b05121 ↗
97. Gonadotropin-releasing hormone receptor-targeted near-infrared fluorescence probe for specific recognition and localization of peritoneal metastases of ovarian cancer
98. Fast and durable intraoperative near-infrared imaging of ovarian cancer using ultrabright squaraine fluorophores10.1002/anie.202117330 ↗
99. Topical pH sensing NIR fluorophores for intraoperative imaging and surgery of disseminated ovarian cancer10.1002/advs.202201416 ↗
100. Debut of a NIR ESIPT-based fluorescent probe with synergistic effects for boosting high-contrast imaging of β-galactosidase in ovarian cancer10.1016/j.snb.2023.134541 ↗